Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar;3(2):151-8.
doi: 10.1161/CIRCOUTCOMES.109.849273. Epub 2010 Jan 12.

Patient reactions to confidentiality, liability, and financial aspects of informed consent in cardiology research

Affiliations

Patient reactions to confidentiality, liability, and financial aspects of informed consent in cardiology research

Alice K Fortune-Greeley et al. Circ Cardiovasc Qual Outcomes. 2010 Mar.

Abstract

Background: Although the informed consent process is supposed to help potential research participants make informed and voluntary decisions about participating in research, little is known about how participants react to language in the informed consent document and whether their reactions are related to their willingness to enroll in clinical trials. We examined the relationship between patients' reactions to standard informed consent language and their willingness to participate in a hypothetical clinical trial.

Methods and results: We simulated the consent process for a hypothetical cardiology clinical trial with 470 patients in an outpatient cardiovascular medicine clinic at a large academic medical center. We analyzed the spontaneous comments and questions that participants made during the interviews about each section of the informed consent document. Few participants made positive comments. Participants made the most negative comments about the sections on risks, study purpose or protocol, and payment for injury. Having a negative reaction to any section was associated with a lower likelihood of participating in the clinical trial. Using a multivariable model, we found that negative reactions in the patient rights, financial disclosure, and confidentiality sections predicted willingness to participate (P<0.001).

Conclusions: Recognizing elements of informed consent that elicit questions and concerns from potential research participants may help investigators design clinical research trials and model language in a way that reduces concerns or increases participant understanding, thereby enhancing informed consent for research.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relationship Between Asking ≥ 1 Question and Willingness to Participate by Section. Note: P values are from a general linear model in which the effects of questions in all sections were considered simultaneously.
Figure 2
Figure 2
Relationship Between Making ≥ 1 Negative Comment and Willingness to Participate by Section. Note: P values are from a general linear model in which the effects of negative comments in all sections were considered simultaneously.

Comment in

Similar articles

References

    1. National Institutes of Health Regulations and Ethical Guidelines. The Belmont Report: ethical principles and guidelines for the protection of human subjects of research. [Accessed December 3, 2008]; http://ohsr.od.nih.gov/guidelines/belmont.html. - PubMed
    1. King SB, 3rd, Barnhart HX, Kosinski AS, Weintraub WS, Lembo NJ, Petersen JY, Douglas JS, Jr, Jones EL, Craver JM, Guyton RA, Morris DC, Liberman HA. Angioplasty or surgery for multivessel coronary artery disease: comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory Angioplasty versus Surgery Trial Investigators. Am J Cardiol. 1997;79:1453–1459. - PubMed
    1. Gorkin L, Schron EB, Handshaw K, Shea S, Kinney MR, Branyon M, Campion J, Bigger JT, Jr, Sylvia SC, Duggan J, Stylianou M, Lancaster S, Ahern DK, Follick MJ. Clinical trial enrollers vs. nonenrollers: the Cardiac Arrhythmia Suppression Trial (CAST) Recruitment and Enrollment Assessment in Clinical Trials (REACT) project. Control Clin Trials. 1996;17:46–59. - PubMed
    1. Sen Biswas M, Newby LK, Bastian LA, Peterson ED, Sugarman J. Who refuses enrollment in cardiac clinical trials? Clin Trials. 2007;4:258–263. - PubMed
    1. Protection of Human Subjects. 45 CFR §46. 1991

Publication types

MeSH terms